EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy

Melanie M Sinanian, Afshan Rahman, Ahmed M Elshazly iD, Victoria Neely, Balaji Nagarajan, Glen E Kellogg iD, April L Risinger iD, David A Gewirtz iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Melanie M Sinanian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Drug Resistance, Neoplasm, Molecular Docking Simulation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: United States Department of Defense, Department of Defense Congressionally Mandated Breast Cancer Research Program, Virginia Commonwealth University Flow Cytometry Shared Resource.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Triple-negative breast cancer (TNBC) is associated with a generally poor prognosis due to its highly aggressive and metastatic nature, lack of targetable receptors, as well as the frequent development of resistance to chemotherapy. We previously reported that AU1, a small molecule developed as an inhibitor of BPTF (bromodomain PHD finger-containing transcription factor), was capable of sensitizing preclinical models of TNBC to chemotherapy in part via the promotion of autophagy. In studies reported here, we identify an additional property of this compound, specifically that sensitization is associated with the inhibition of the P-glycoprotein (P-gp) efflux pump. In silico molecular docking studies indicate that AU1 binds to active regions of the efflux pump in a manner consistent with the inhibition of the pump function. This work identifies a novel chemical structure that can influence multidrug efflux, an established mechanism of drug resistance in TNBC, that has not yet been successfully addressed by clinical efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Triple Negative Breast NeoplasmsDrug Resistance, NeoplasmMolecular Docking SimulationFemaleAnimalsMiceCell Line, TumorHumansTranscription FactorsDrug Resistance, MultipleAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1

Stichwörter der Autor:innen

AU1BPTF inhibitorP-glycoproteinP-gpbreast cancerefflux pumpmultidrug resistancemultidrug resistance pumptriple-negative breast cancer

Substanzen

Transcription FactorsAntineoplastic AgentsATP Binding Cassette Transporter, Subfamily B, Member 1

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Kafrelsheikh University, Kafrelsheikh 33516, Egypt.
  • Philips Institute for Oral Health Research, School of Dentistry, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA 23298, USA.
  • Department of Pharmacology, University of Texas Health Science Center, San Antonio, TX 78229, USA.

ORCID-Profile: Ahmed M Elshazly, Glen E Kellogg, April L Risinger, David A Gewirtz

Förderung

  • United States Department of Defense
  • Department of Defense Congressionally Mandated Breast Cancer Research Program
  • Virginia Commonwealth University Flow Cytometry Shared Resource
  • NIH-NCI Cancer Center Support

Zitieren

APA

Sinanian, M. M., Rahman, A., Elshazly, A. M., Neely, V., Nagarajan, B., Kellogg, G. E., Risinger, A. L., & Gewirtz, D. A. (2024). A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111346

Vancouver

Sinanian MM, Rahman A, Elshazly AM, Neely V, Nagarajan B, Kellogg GE, et al. A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111346

BibTeX
@article{Sinanian2024,
  author = {Sinanian, Melanie M and Rahman, Afshan and Elshazly, Ahmed M and Neely, Victoria and Nagarajan, Balaji and Kellogg, Glen E and Risinger, April L and Gewirtz, David A},
  title = {A BPTF Inhibitor That Interferes with the Multidrug Resistance Pump to Sensitize Murine Triple-Negative Breast Cancer Cells to Chemotherapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111346}
}
Kostenlos starten →